SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-002394
Filing Date
2023-01-25
Accepted
2023-01-25 09:05:40
Documents
14
Period of Report
2023-01-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38390
2 ex99-1.htm EX-99.1 17226
3 ex99-1_001.jpg GRAPHIC 5589
  Complete submission text file 0001493152-23-002394.txt   242611

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pulm-20230125.xsd EX-101.SCH 3230
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pulm-20230125_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pulm-20230125_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3601
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 23549956
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences